RPID Stock Analysis: Buy, Sell, or Hold?
RPID - Rapid Micro Biosystems, Inc. Class A Common Stock
$1.96
-0.11 (-5.56%)
▼
5d:
-24.22%
30d:
-14.25%
90d:
-50.38%
HOLD
MODERATE Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When RPID Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RPID shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RPID shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RPID is currently trading at $1.96, which is considered oversold relative to its 30-day fair value range of $2.17 to $2.51.
Technical Outlook: Technically, RPID is in a strong downtrend. The price is currently testing key support at $1.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: RPID has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.00 (+286.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RPID is in a strong downtrend. The price is currently testing key support at $1.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: RPID has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.00 (+286.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.17 -
$2.51
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.6%)
- BULLISH: Trading 286.5% below Wall St target ($8.00)
- CAUTION: 5-day price weakness (-24.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.17 -
$2.51
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.91
Resistance Level
$2.70
Current Trend
Strong Downtrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.61
Wall Street Target
$8.00
(+286.5%)
Revenue Growth (YoY)
11.1%
Profit Margin
-145.8%
Share & Embed Analysis
Last updated: May 18, 2026 2:44 PM ET
Data refreshes hourly during market hours. Next update: 3:44 PM
Data refreshes hourly during market hours. Next update: 3:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RPID showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Sean M Wirtjes
SELL
7480 shares
2026-03-11
John J Addington Wilson
SELL
9603 shares
2026-03-11
Robert G Jr. Spignesi
SELL
17922 shares
2026-03-10
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 57 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
